专题：Cancer Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and molecular characterization of Cancer of Unknown Primary (CUP) site. It includes research on metastatic patterns, molecular profiling to identify tissue of origin, immunohistochemical markers, diagnostic algorithms, and clinical management strategies.
最新文献
Atypical Pulmonary Metastases: Patterns and Clinical Significance

article Full Text OpenAlex

Osimertinib-induced aplastic anemia after curative surgery for EGFR-mutant lung adenocarcinoma

article Full Text OpenAlex

International expert consensus on the clinical integration of circulating tumor cells in solid tumors

article Full Text OpenAlex

Human Papillomavirus Infection as a Risk Factor for Oral Leukoplakia: A Systematic Review and Meta-Analysis

review Full Text OpenAlex

Digital Papillary Adenocarcinoma of the Vulva

article Full Text OpenAlex

Prophylactic photobiomodulation to reduce oral mucositis in head and neck cancer: an observational study

article Full Text OpenAlex

A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy

review Full Text OpenAlex

Pulmonary Metastasectomy: A Multicenter Comparison of Wedge Resection Versus Anatomic Resection for Single Metastases of Colorectal Cancer

article Full Text OpenAlex

Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab

article Full Text OpenAlex

A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24)

article Full Text OpenAlex

近5年高被引文献
American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update

review Full Text OpenAlex 908 FWCI133.62133155

A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.

article Full Text OpenAlex 230 FWCI68.93935073

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

review Full Text OpenAlex 182 FWCI84.12304419

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

article Full Text OpenAlex 171 FWCI55.93763108

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 167 FWCI24.87710409

Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature

review Full Text OpenAlex 164 FWCI55.32949763

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

article Full Text OpenAlex 161 FWCI7.84070188

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (E2108)

article Full Text OpenAlex 157 FWCI21.75304254

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

article Full Text OpenAlex 146 FWCI28.98683724

Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

review Full Text OpenAlex 139 FWCI28.07109344